Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLAX:US

55.54 USD 0.04 0.07%

As of 09:29:30 ET on 05/22/2015.

Snapshot for Prudential Jennison Health Sciences Fund (PHLAX)

Year To Date: +16.51% 3-Month: +6.46% 3-Year: +38.26% 52-Week Range: 36.58 - 56.44
1-Month: -0.66% 1-Year: +57.22% 5-Year: +32.12% Beta vs SPR: 0.96

Mutual Fund Chart for PHLAX

No chart data available.
  • PHLAX:US 55.54
  • 1M
  • 1Y
Interactive PHLAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLAX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLAX

NAV (on 2015-05-22) 55.54
Assets (M) (on 2015-05-21) 3,747.95
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-23) 1.84
Dividend Yield (ttm) 12.44

Fees & Expenses for PHLAX

Front Load 5.50
Back Load 1.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.15

Top Fund Holdings for PHLAX

Filing Date: 03/31/2015
Name Position Value % of Total
BioMarin Pharmaceutical Inc 1,752,708 218,422,471 6.156%
Shire PLC 581,006 139,028,926 3.919%
Actavis plc 459,137 136,648,354 3.852%
Incyte Corp 1,287,134 117,978,702 3.325%
Biogen Inc 275,374 116,273,918 3.277%
Medtronic PLC 1,464,260 114,197,637 3.219%
Intercept Pharmaceuticals Inc 383,706 108,212,766 3.050%
Celgene Corp 876,811 101,078,772 2.849%
Alnylam Pharmaceuticals Inc 787,111 82,190,131 2.317%
AstraZeneca PLC 1,150,144 78,704,354 2.218%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil